Early Detection of At-risk Septic Patients (MMICS)

An Observational Pilot Study for the Multi-Modality Risk Prediction and Early Identification of Critically Ill Septic Patients in the Emergency Department

The purpose of this study is to determine whether additional investigations used in other parts of healthcare can be used in the Emergency Department to identify critically ill patients quicker than usual care.

Study Overview

Detailed Description

The investigators intend to recruit 56 patients with suspected sepsis who attend the Emergency Department. The investigators want to use a device to monitor tissue oxygen levels when they first come into the Emergency Department as well as the change in tissue oxygen levels when a tourniquet is applied for 3 minutes. The investigators will take novel blood tests when the patient is having their routine bloods. Finally, the investigators will use a special camera to take specialised pictures of the small blood vessels under the tongue which will show blood flow through these vessels. The investigators will follow the recruited patients and determine if our extra data is better at determining who needs critical care. A significant proportion of patients may be too unwell or too distressed to consent to be part of this study. At the earliest opportunity, the investigators will ask patients when they have been stabilised and are able to give consent. If they say no, they will be removed from the study and their care will not be affected by this decision.

The results could help us identify septic shock as early as possible so that these unwell patients are identified early and get the correct treatment they need. This could mean starting advanced treatments usually found in the Intensive Care Unit very early on in a patient's journey.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hampshire
      • Southampton, Hampshire, United Kingdom, SO16 6YD
        • Recruiting
        • University Hospital Southampton NHS Foundation Trust
        • Contact:
          • James N Ward, BM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients presenting to the Emergency Department with their illness possibly caused by sepsis

Description

Inclusion Criteria:

  1. Differential diagnosis which includes infection
  2. Change in the quick Sequential Organ Failure Assessment (qSOFA) ≥2 or National Early Warning Score 2 (NEWS2) score ≥5
  3. Aged ≥18 years

Exclusion Criteria:

  1. Traumatic injury
  2. Rockwood frailty score ≥6
  3. Critical care therapy previously believed to not be in patient's best interests
  4. Critical care therapies-initiated pre-hospital. Critical care therapies defined as:

    4.1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital transfusion of blood products 4.5 Extra-corporeal support

  5. Advanced directive refusing critical care therapies.
  6. Acute cardiac failure
  7. Active gastrointestinal bleed
  8. Massive pulmonary embolism
  9. ICU admission declined by critical care team
  10. Treated in an acute hospital <6 hours before presentation to the Emergency Department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients presenting to the Emergency Department with suspected sepsis
Patients who present with potential sepsis. This is characterised by their illness suspected to be from an infection and significantly unwell defined by one of two scoring systems, either the National Early Warning Score or quick Sequential Organ Failure Assessment
Measuring oxygen content of arteries, capillaries and veins
Blood test
Other Names:
  • PCT
Blood test looking at inflammation in the body
Other Names:
  • MR-proADM
A handheld video microscope that looks at blood flow through the capillaries of the tongue

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in tissue oxygenation
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
The difference in tissue oxygen saturation (StO2) during the vascular occlusion test in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in % change per second..
Up to 4 hours (from baseline); 28 days (follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline of tissue oxygenation
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
The difference in tissue oxygen saturation (StO2) at baseline in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in %.
Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood flow of the micro-circulation (microvascular flow index)
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the Microvascular Flow Index (arbitrary units) which is a validated measurement assessing micro-circulatory flow.
Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood flow of the micro-circulation (perfused vessel density)
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the perfused vessel density (measured in mm/mm2) which is a validated measurement assessing micro-circulatory flow.
Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood lactate levels
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
The difference in the blood tests of lactate between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood tests (MR-proADM)
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
The difference in the blood tests of MR-proADM between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood tests (Procalcitonin)
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
The difference in the blood tests of Procalcitonin (PCT) between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Up to 4 hours (from baseline); 28 days (follow-up)
Correlation of extra investigations with standard patient outcomes
Time Frame: Up to 4 hours (from baseline); 28 days (follow-up)
Looking at whether tissue oxygenation, buccal microcirculation (blood flow under the tongue) and biomarkers and correlation with clinical outcomes such as organ failure (SOFA) scores, 28-day hospital mortality, and length of hospital and ICU stay.
Up to 4 hours (from baseline); 28 days (follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ahilanandan Dushianthan, PhD, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: James N Ward, BM, University Hospital Southampton NHS Foundation Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2024

Primary Completion (Estimated)

August 6, 2025

Study Completion (Estimated)

August 6, 2025

Study Registration Dates

First Submitted

January 8, 2024

First Submitted That Met QC Criteria

February 7, 2024

First Posted (Actual)

February 12, 2024

Study Record Updates

Last Update Posted (Estimated)

December 2, 2024

Last Update Submitted That Met QC Criteria

November 27, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CRI0436

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data (IPD) that underlie results in a publication will be shared

IPD Sharing Time Frame

6 months after publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on Measuring tissue oxygenation

Subscribe